After-hours 16:57 (ET)CAPR Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-0.70
Revenue Actual (USD)0.00
Capricor Therapeutics Inc Earnings Dates & Reports
This page offers detailed Capricor Therapeutics Inc earnings data including the latest Capricor Therapeutics Inc earnings report, the upcoming Capricor Therapeutics Inc earnings date, historical data and Capricor Therapeutics Inc earnings call news.
CAPR Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
CAPR FY2025 Earnings
EPS (YoY)-2.26-96.69%
Revenue (YoY)0.00-100.00%
Capricor Therapeutics Inc (CAPR) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.70/-0.59 | 0.00/0.00 | -19.19% | -- |
| 5/12/2026 | 03/2026 | -0.59/-0.53 | 0.00/0.00 | -11.20% | -- |
| 3/12/2026 | 12/2025 | -0.62/-0.54 | 0.00/0.00 | -14.37% | -- |
| 11/10/2025 | 09/2025 | -0.54/-0.55 | 0.00/533.33K | 1.83% | -100.00% |
| 8/11/2025 | 06/2025 | -0.57/-0.47 | 0.00/778.00K | -20.89% | -100.00% |
| 5/13/2025 | 03/2025 | -0.53/-0.32 | 0.00/1.79M | -68.78% | -100.00% |
| 3/19/2025 | 12/2024 | -0.16/-0.26 | 11.13M/5.68M | 39.37% | 95.90% |
| 11/13/2024 | 09/2024 | -0.38/-0.36 | 2.26M/3.57M | -5.90% | -36.62% |
Capricor Therapeutics Inc Latest Earnings Call Transcripts
Capricor Therapeutics (CAPR) Q2 2026 Earnings Call: Deramocel BLA Path and FDA Update
Capricor Therapeutics’ Q2 2026 earnings call covered its deramocel BLA amendment plan, $237.9 million cash balance and $40.7 million net loss.